SureTrader Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: dshade, dadx4
Search This Board:
Last Post: 4/28/2016 10:40:47 AM - Followers: 311 - Board type: Free - Posts Today: 0

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 04/05/2016 08:06:43 AM
ONVO News: Current Report Filing (8-k) 02/08/2016 04:11:41 PM
ONVO News: Quarterly Report (10-q) 02/08/2016 04:09:04 PM
ONVO News: Securities Registration: Employee Benefit Plan (s-8) 02/04/2016 04:55:53 PM
ONVO News: Statement of Ownership (sc 13g) 01/28/2016 04:01:31 PM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#9201   Time for me to hop back in this. hwpbnj 04/28/16 10:40:47 AM
#9200   Nice rayank 04/26/16 04:35:54 PM
#9199   Thomson Reuters/Verus upgrades ORGANOVO HOLDINGS INC from SELL RandolRocketman 04/26/16 01:54:41 PM
#9198   Looks like someone thought this was worth a RandolRocketman 04/21/16 12:29:51 PM
#9197   Volume is low but action is good....up by Alvie 04/21/16 11:41:30 AM
#9191   I was in small time and broke even...HOW lighter than AIR 04/19/16 02:49:42 PM
#9190   I mean ouch look at that. Literally after RallyTheMarket 04/19/16 02:47:25 PM
#9189   took off? I must have missed that. lighter than AIR 04/19/16 02:47:22 PM
#9188   Not acting much like DDD today. I'm liking Ballgame 04/19/16 02:46:35 PM
#9187   Sorry you got out at $2.18. Bummer to RallyTheMarket 04/19/16 02:45:41 PM
#9186   So does going back to lighter than AIR 04/19/16 02:39:29 PM
#9185   This is a needed pullback as we were Ballgame 04/15/16 02:25:10 PM
#9184   I see us picking right back up with Ballgame 04/15/16 10:59:05 AM
#9183   Yep...agreed...there was no reason for ONVO to react wiredawg 04/14/16 06:07:11 PM
#9182   I see $2.50 possible, not $2.00, as the rayank 04/14/16 04:55:29 PM
#9181   While I rarely prognosticate, I feel that $3 dadx4 04/14/16 03:56:17 PM
#9180   Can't ask for much more than a 16% RallyTheMarket 04/14/16 03:51:42 PM
#9179   Agree about it tracking DDD and both loook Tim501 04/14/16 03:38:35 PM
#9178   I was just wondering about the L2 Ballgame 04/14/16 01:55:17 PM
#9177   More likely to hit $2 before $3. This RandolRocketman 04/14/16 01:52:32 PM
#9176   How are we looking sfter $2.91 resistance? Ballgame 04/14/16 01:41:25 PM
#9175   ONVO--GLTA! dadx4 04/14/16 11:33:10 AM
#9174 RandolRocketman 04/14/16 11:19:27 AM
#9173   Where did you get this number? I see... 3-31-16: RallyTheMarket 04/14/16 10:41:18 AM
#9172   Shorts down another .4% RandolRocketman 04/14/16 10:37:12 AM
#9171   Yep Alvie, still adding and avg up. dshade 04/14/16 10:18:48 AM
#9170   I can only hope it drives shorts to RallyTheMarket 04/14/16 10:17:31 AM
#9169   Yeah I was just thinking that after I Ballgame 04/14/16 10:14:43 AM
#9168   600,000 shares in the first 40 minutes isn't Alvie 04/14/16 10:13:44 AM
#9167   Ha. I know what you are saying. Sadly the Ballgame 04/14/16 10:11:52 AM
#9166   Unfortunately that's all we have to go on RallyTheMarket 04/14/16 10:09:21 AM
#9165   I think it's the chart readers really really Ballgame 04/14/16 10:06:01 AM
#9164   Do they get a piece of the discovery RandolRocketman 04/13/16 10:50:22 PM
#9163   I think you meant to say the Kidney pennytiger 04/13/16 09:15:06 PM
#9162   I'll skip right to the tl;dr of my RallyTheMarket 04/13/16 08:15:57 PM
#9161   A 33700 block traded at 6:32pm ET at Tim501 04/13/16 07:18:16 PM
#9160   With ONVO you can never tell because management RallyTheMarket 04/13/16 04:19:09 PM
#9159   ONVO---NICE DAY---GLTA! dadx4 04/13/16 04:09:57 PM
#9158   On April 8, 2016 Columbine Capital Services, Inc. RandolRocketman 04/13/16 04:05:41 PM
#9157   Closed at 2.50, up 7.3% today. I don't RandolRocketman 04/13/16 04:03:04 PM
#9155   Very good volume and upward price movement today. Ballgame 04/13/16 12:40:18 PM
#9154   MACD screaming lift off here. Hope so Ballgame 04/11/16 03:04:55 AM
#9153   Yeah I thought so too. You are welcome. :-) rayank 03/31/16 04:04:46 PM
#9152   Great article...thanks for the link! PaperLion 03/31/16 03:57:52 PM
#9151   Realistic (imo) positive SA article: rayank 03/31/16 09:24:50 AM
#9150   As if it means ANYTHING RallyTheMarket 03/30/16 05:51:24 PM
#9149   Wise move by them. dshade 03/30/16 04:44:10 PM
#9148   On March 28, 2016 Thomson Reuters/Verus upgraded ORGANOVO RandolRocketman 03/29/16 02:30:30 PM
#9147   Ouch...glad I got out at 2.18...not looking good lighter than AIR 03/23/16 03:45:57 PM
#9140   Hey what's going on here? I think BIG RallyTheMarket 03/17/16 05:50:10 PM